Sympazan Film
Product Images NDC 10094-220

13 FDA label images from Aquestive Therapeutics · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Sympazan (NDC 10094-220). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aquestive Therapeutics, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

The Following Structural Formula For Sympazantm Contains -clobazam,a Benzodiazepine Derivative, Which Is Chemically Known As 7-chloro-1-methyl-5-phenyl-1h-1,5 Benzodiazepine-2,4(3h,5h)-dione With A Molecular Formula Of C16h13 Cln2o2 , Molecular Weight Of 300.74. (Sympazan 01)

The Following Structural Formula For Sympazantm Contains -clobazam,a Benzodiazepine Derivative, Which Is Chemically Known As 7-chloro-1-methyl-5-phenyl-1h-1,5 Benzodiazepine-2,4(3h,5h)-dione With A Molecular Formula Of C16h13 Cln2o2 , Molecular Weight Of 300.74. (Sympazan 01)
Chemical structure of clobazam, the active ingredient in SYMPAZAN. The structure shows a benzodiazepine core with chlorinated and methyl substituents, and two carbonyl groups attached to a fused ring system.*
FDA Label Image

Figure 1: Mean Percent Reduction From Baseline In Weekly Drop Seizure Frequency (study 1) (Sympazan 02)

Figure 1:	Mean Percent Reduction From Baseline In Weekly Drop Seizure Frequency (study 1) (Sympazan 02)
A bar chart showing percentage reduction in weekly drop seizure rate for four groups: Placebo, Low, Medium, and High doses of the drug. The chart includes values approximately -12.1%, -41.2%, -49.4%, and -68.3%, respectively, with statistical significance indicated for some bars.*
FDA Label Image

Figure 2: Drop Seizure Response By Category For Clobazam And Placebo (study 1) (Sympazan 03)

Figure 2:	Drop Seizure Response By Category For Clobazam And Placebo (study 1) (Sympazan 03)
A bar chart showing the proportion of patients (percentage) categorized by change in weekly drop seizure frequency from baseline across four groups: Placebo, Clobazam Low, Clobazam Medium, and Clobazam High. The x-axis represents ranges of seizure frequency change, and the y-axis shows the proportion of patients in percentage, illustrating differences in seizure frequency improvement among treatment groups.*
FDA Label Image

Step 1. Open Pouch (Sympazan 05)

Step 1. Open Pouch (Sympazan 05)
An instructional illustration demonstrating how to open a container or package by lifting a flap or lid. The image shows two steps with arrows indicating the direction to lift or peel back the corner of the package.*
FDA Label Image

Step 2. Remove Film (Sympazan 06)

Step 2. Remove Film (Sympazan 06)
An instructional illustration showing hands peeling a film strip from a backing. The image demonstrates how to properly remove an oral film dosage form, relevant for products like SYMPAZAN clobazam oral films.*
FDA Label Image

Step 3. Place On Tongue (Sympazan 07)

Step 3. Place On Tongue (Sympazan 07)
Illustration showing a person placing a film dosage form on their tongue, demonstrating the oral administration of SYMPAZAN (clobazam) film. The image highlights the correct method of taking this prescription drug by mouth.*
FDA Label Image

Step 4. Close Mouth And Swallow Saliva Normally (Sympazan 08)

Step 4. Close Mouth And Swallow Saliva Normally (Sympazan 08)
An illustration showing a side profile of a human face and neck region, indicating oral administration. This image is likely used to demonstrate how the SYMPAZAN oral film dosage form should be taken by placing it in the mouth.*
FDA Label Image

Principal Display Panelndc 10094-205-01sympazan(clobazam) Oral Film5 mgrx Only1 Oral Films (Sympazan 09)

Principal Display Panelndc 10094-205-01sympazan(clobazam) Oral Film5 mgrx Only1 Oral Films (Sympazan 09)
Label for Sympazan 5 mg oral film containing clobazam, manufactured by Aquestive Therapeutics. The label shows directions to open and use the film on the tongue without cutting or chewing. It indicates storage instructions, the NDC number 10094-205-01, and states the product is Rx only with one oral film per package.*
FDA Label Image

Principal Display Panelndc 10094-205-60sympazan(clobazam) Oral Film5 mgrx Only60 Oral Films (Sympazan 0a)

Principal Display Panelndc 10094-205-60sympazan(clobazam) Oral Film5 mgrx Only60 Oral Films (Sympazan 0a)
The packaging label for SYMPAZAN 5 mg oral film contains clobazam as the active ingredient. It is an oral film dosage form supplied in a package size of 60 films. The label includes usage directions, storage instructions, and a note to pharmacists to include the medication guide with each prescription. The product is labeled for prescription use only and is manufactured by Aquestive Therapeutics.*
FDA Label Image

Principal Display Panelndc 10094-210-01sympazan(clobazam) Oral Film10 mgrx Only1 Oral Films (Sympazan 0b)

Principal Display Panelndc 10094-210-01sympazan(clobazam) Oral Film10 mgrx Only1 Oral Films (Sympazan 0b)
Packaging label for Sympazan 10 mg oral film containing clobazam, produced by Aquestive Therapeutics. The label includes instructions to fold along the solid line and tear down at the slit to open. It advises not to cut or chew the oral film. The package contains one oral film and is Rx only. Storage instructions and manufacturer details are also visible.*
FDA Label Image

Principal Display Panelndc 10094-210-60sympazan(clobazam) Oral Film10 mgrx Only60 Oral Films (Sympazan 0c)

Principal Display Panelndc 10094-210-60sympazan(clobazam) Oral Film10 mgrx Only60 Oral Films (Sympazan 0c)
Packaging label for Sympazan clobazam oral film, 10 mg strength. The label indicates 60 oral films per package, prescription only, manufactured by Aquestive Therapeutics. Instructions include keeping the film on the tongue until dissolved and not cutting or chewing the film. The label includes storage instructions and a QR code along with a barcode.*
FDA Label Image

Principal Display Panelndc 10094-220-01sympazan(clobazam) Oral Film20 mgrx Only1 Oral Films (Sympazan 0d)

Principal Display Panelndc 10094-220-01sympazan(clobazam) Oral Film20 mgrx Only1 Oral Films (Sympazan 0d)
Label for Sympazan (clobazam) oral film, 20 mg strength. The label includes instructions to open by folding and tearing along the indicated lines, usage directions to place the film on the tongue and keep it until dissolved, and storage instructions. The product is manufactured by Aquestive Therapeutics and is available as a single oral film dose. The label also cautions against cutting or chewing the film and indicates prescription-only status.*
FDA Label Image

Principal Display Panelndc 10094-220-60sympazan(clobazam) Oral Film20 mgrx Only60 Oral Films (Sympazan 0e)

Principal Display Panelndc 10094-220-60sympazan(clobazam) Oral Film20 mgrx Only60 Oral Films (Sympazan 0e)
The packaging label for Sympazan 20 mg oral film shows it contains clobazam as the active ingredient. The box holds 60 oral films and is manufactured by Aquestive Therapeutics. Directions advise placing the film on the tongue until it dissolves, with a warning not to cut or chew the film. Storage instructions and medication guide inclusion for pharmacists are noted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.